Latest Regulatory News

Page 710 of 743
Paradigm Biopharmaceuticals has secured FDA clearance for its phase 3 knee osteoarthritis trial and raised $16 million to fund its next clinical steps, positioning the company for a pivotal year ahead.
Ada Torres
Ada Torres
30 Jan 2025
NSX Limited reports a $1.6 million cash injection from ISXFEU, completes the ClearPay joint venture sale, and reduces operational costs in its 2Q25 activities report, while facing delays in share issuance approval.
Claire Turing
Claire Turing
30 Jan 2025
Latitude Group Holdings Limited has announced a quarterly distribution of AUD 2.2291 per Capital Note, payable in late April 2025, continuing its steady income stream for investors.
Claire Turing
Claire Turing
30 Jan 2025
BlinkLab has launched its pivotal FDA registrational study for its AI-driven autism diagnostic app, BlinkLab Dx 1, following positive FDA feedback and promising preliminary results.
Ada Torres
Ada Torres
30 Jan 2025
Icon Energy Limited reported a $455K cash balance and issued 100 million shares this quarter to sustain operations amid ongoing uncertainty over the ATP 855 permit renewal.
Victor Sage
Victor Sage
30 Jan 2025
Dome Gold Mines reports steady progress on its Sigatoka industrial sand and magnetite project alongside securing a key government contract for emergency river desilting in Fiji. Exploration results also highlight promising copper and gold anomalies at its Nadroga tenement.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Carbine Resources reports steady progress on its Muchea West silica sand mining licence application, engaging environmental consultants to support upcoming approvals. The company also continues exploration efforts at its Down South project.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Enova Mining has completed a significant drilling campaign at its CODA North project, confirming high-grade rare earth element mineralisation, while securing $1.5 million in new funding to accelerate exploration and metallurgical testing.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Zelira Therapeutics has secured a fourth funding tranche of US$681,000, advancing its HOPE® Autism Spectrum Disorder FDA trial process and bringing total funding to US$3.25 million. The company is progressing clinical validation and product development, including the transformation of Zenivol® into a capsule formulation.
Ada Torres
Ada Torres
30 Jan 2025
Echo IQ Limited has secured FDA clearance for its EchoSolv AS technology and appointed a US-based CEO, marking a pivotal shift towards commercialisation in the American healthcare market.
Ada Torres
Ada Torres
30 Jan 2025
Traka Resources reports steady progress in its December 2024 quarter, focusing on exploration at Gorge Creek and Cranbrook while withdrawing from Mozambique projects to sharpen its strategic focus.
Maxwell Dee
Maxwell Dee
30 Jan 2025
MFF Capital Investments Limited has announced a fully franked ordinary dividend of AUD 0.08 per share, payable in May 2025, alongside shareholder-friendly reinvestment and bonus security plans.
Claire Turing
Claire Turing
30 Jan 2025